Form 8.3 - Aer Lingus Group plc
Tweet
Share
E-mailTORONTO, ONTARIO -- (Marketwired) -- 03/17/15 --
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
----------------------------------------------------------------------------
Name of person dealing (Note 1) The Canada Life Assurance Company, The
Great-West Life Assurance Company,
Great-West Life & Annuity Insurance
Company, I.G. Investment Management,
Ltd., Irish Life Investment
Managers Limited, London Life
Insurance Company, PanAgora Asset
Management Inc., The Putnam Advisory
Company, LLC, Putnam Investments
Limited, Putnam Investment Management,
LLC, and Setanta Asset Management
Limited, all of which are investment
management subsidiaries of Power
Corporation of Canada
----------------------------------------------------------------------------
Company dealt in Aer Lingus Group plc
----------------------------------------------------------------------------
Class of relevant security to which
the dealings being disclosed relate EUR0.05 ordinary shares (ISIN:
(Note 2) IE00B1CMPN86)
----------------------------------------------------------------------------
Date of dealing 13 March 2015
----------------------------------------------------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
----------------------------------------------------------------------------
Long Short
----------------------------------------------------------------------------
Number (%) Number (%)
----------------------------------------------------------------------------
(1) Relevant securities 19,507,049 (3.65%)
----------------------------------------------------------------------------
(2) Derivatives (other than options)
----------------------------------------------------------------------------
(3) Options and agreements to
purchase/sell
----------------------------------------------------------------------------
Total 19,507,049 (3.65%)
----------------------------------------------------------------------------
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
----------------------------------------------------------------------------
Class of relevant security: Long Short
----------------------------------------------------------------------------
Number (%) Number (%)
----------------------------------------------------------------------------
(1) Relevant securities
----------------------------------------------------------------------------
(2) Derivatives (other than options)
----------------------------------------------------------------------------
(3) Options and agreements to
purchase/sell
----------------------------------------------------------------------------
Total
----------------------------------------------------------------------------
3. DEALINGS (Note 4)
(a) Purchases and sales
----------------------------------------------------------------------------
Purchase/sale Number of relevant Price per unit (Note 5)
securities
----------------------------------------------------------------------------
Buy 87,963 2.33 Euro
----------------------------------------------------------------------------
Buy 12,037 2.33 Euro
----------------------------------------------------------------------------
----------------------------------------------------------------------------
----------------------------------------------------------------------------
(b) Derivatives transactions (other than options transactions)
----------------------------------------------------------------------------
Product name, Nature of Number of Price per unit (Note 5)
e.g. CFD transaction relevant
(Note 6) securities
(Note 7)
----------------------------------------------------------------------------
----------------------------------------------------------------------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
----------------------------------------------------------------------------
Product Writing, Number of Exercise Type, Expiry Option money
name, e.g. selling, securities price e.g. date paid/received
call option purchasing, to which American, per unit
varying etc.the option European (Note 5)
relates etc.
(Note 7)
----------------------------------------------------------------------------
----------------------------------------------------------------------------
----------------------------------------------------------------------------
(ii) Exercising
----------------------------------------------------------------------------
Product name, Number of Exercise price per unit (Note 5)
e.g. call securities
option
----------------------------------------------------------------------------
----------------------------------------------------------------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
----------------------------------------------------------------------------
Nature of transaction Details Price per unit
(Note 8) (if applicable)(Note 5)
----------------------------------------------------------------------------
----------------------------------------------------------------------------
----------------------------------------------------------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
----------------------------------------------------------------------------
Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of any
relevant securities under any option referred to on this form or relating
to the voting rights or future acquisition or disposal of any relevant
securities to which any derivative referred to on this form is referenced.
If none, this should be stated.
----------------------------------------------------------------------------
----------------------------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) No
----------------------------------------------------------------------------
Date of disclosure 17 March 2015
----------------------------------------------------------------------------
Contact name John Mulligan
----------------------------------------------------------------------------
Telephone number 204-956-8653
----------------------------------------------------------------------------
If a connected EFM, name of offeree/offeror
with which connected
----------------------------------------------------------------------------
If a connected EFM, state nature of
connection (Note 10)
----------------------------------------------------------------------------
Contacts: John Mulligan 204-956-8653
Source: Investors Group
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TechMediaBreaks – Nocera, Inc. (NASDAQ: NCRA) Acquires Controlling Interest in Taiwan Memory Distributor to Advance AI Infrastructure Strategy
- New Data Show Seed's Co-Biotics Increase Bioactive Vitamin B3, Gut-Brain Metabolites, and Sleep-Related Tryptophan Through the Microbiome
- LACARAF Sets a New Standard for Wine Enjoyment Through Unprecedent Temperature Precision
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Putnam Investments, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
